Relation of C-Reactive Protein Level and Long-Term Risk of Death or Myocardial Infarction Following Percutaneous Coronary Intervention With a Sirolimus-Eluting Stent

American Journal of Cardiology

Volumn 98, Issue 5, 2006, Pages 616-618

  Karha, Juhana ^a   Bavry, Anthony A ^a   Rajagopal, Vivek ^a   Henderson, Mark R ^a   Ellis, Stephen G ^a   Brener, Sorin J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RAPAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HOSPITAL; HUMAN; HYPOTHESIS; INCIDENCE; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK ASSESSMENT; RISK MANAGEMENT; STATISTICAL ANALYSIS; STENT; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; C-REACTIVE PROTEIN; COATED MATERIALS, BIOCOMPATIBLE; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OHIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; STENTS; SURVIVAL RATE; TIME FACTORS;

EID: 33747194170     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.039     Document Type: Article

References (6)

1. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
2. Dibra A., Mehilli J., Braun S., Hadamitzky M., Baum H., Dirschinger J., Schuhlen H., Schomig A., and Kastrati A. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J 150 (2005) 344-350
3. de la Torre-Hernandez J.M., Sainz-Laso F., Burgos V., Perez T., Figueroa A., Zueco J., and Colman T. Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents. Am J Cardiol 95 (2005) 748-751
4. Naoum J.J., Woodside K.J., Zhang S., Rychahou P.G., and Hunter G.C. Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in apo-E knockout mice. Transplant Proc 37 (2005) 1880-1884
5. Curb J.D., Ford C.E., Pressel S., Palmer M., Babcock C., and Hawkins C.M. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol 121 (1985) 754-766
6. Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., Topol E.J., and Ellis S.G. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-997